A randomized phase II study of gemcitabine (G) and carboplatin (C) with or without cediranib (AZD2171 [CED]) as first-line therapy in advanced non-small cell lung cancer (NSCLC).
- Citation:
- J Clin Oncol vol 28 (15s) abstr 7603
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 1009
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. K. Dy S. J. Mandrekar G. D. Nelson H. J. Ross R. H. Ansari A. P. Lyss P. J. Stella S. E. Schild J. R. Molina A. A. Adjei
- Networks:
- Study
- NCCTG-N0528
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: